DONEPEZIL, DONEPEZIL
APHP201183
Approved small_molecule active
Quick answer
DONEPEZIL, DONEPEZIL for Interest of adding donepezil to the non-medicinal care pathway recommended in France for Alzheimer's disease is a Approved program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Interest of adding donepezil to the non-medicinal care pathway recommended in France for Alzheimer's disease
- Phase
- Approved
- Modality
- small_molecule
- Status
- active